Elsevier closes Interfolio acquisition

Elsevier(opens in new tab/window), a global leader in research publishing and information analytics, and part of RELX(opens in new tab/window), has closed the acquisition of Interfolio(opens in new tab/window), a provider of advanced faculty information solutions for higher education, headquartered in Washington DC, US.

For over 20 years, Interfolio has supported academics, researchers, higher education institutions and funders. Interfolio’s portfolio includes Faculty Information System (FIS)(opens in new tab/window), Dossier, and Researchfish(opens in new tab/window). Faculty Information System enables academics to collect and manage critical data for academic hiring, review, promotion and tenure, through a streamlined and transparent digital process, using faculty activity data which benefits the scholar and the institution. Researchfish technology helps funders and research organisations to collect, track, assess, and gain deep insights into research outputs, outcomes and impacts. Dossier helps individual scholars and researchers to aggregate and efficiently apply for faculty positions and graduate programs.

Andrew Rosen, Chief Executive Officer at Interfolio, said: “I am incredibly proud of everyone at Interfolio. We have a singular focus: helping our customers to understand and effectively manage the huge amount of activity that scholars accomplish. As part of Elsevier, we will retain this focus and strengthen our core products for our customers. We will aim to support more institutions internationally, increase data automation to help our customers improve efficiency, and provide sophisticated analytics tools to expand insights and facilitate scholarly work. This is an exciting next step for our business, and I look forward to working with the Elsevier team.”

Interfolio will be part of Elsevier’s Research Intelligence(opens in new tab/window) portfolio, which includes

Scopus, SciVal(opens in new tab/window), Pure and Digital Commons.(opens in new tab/window) The combined portfolio will deliver analysis and insights that help academic researchers, research leaders, institutions and funders achieve their strategic goals.

Theo Pillay, General Manager of Research Institutional Products at Elsevier, said: “Interfolio has an unparalleled understanding of scholarly faculty activity and managing research assessment data. Its solutions will strengthen our Research Intelligence portfolio and there are strong synergies that will help us deliver increased and accelerated value to both Elsevier and Interfolio customers and users. I am very pleased to welcome the Interfolio team to Elsevier.”

Macquarie Capital served as exclusive financial advisor to Interfolio.

---

About Interfolio

Conceived by academics for academics, Interfolio is an education technology company headquartered in Washington, DC, US. Founded in 1999, Interfolio serves colleges and universities, funders and research organizations, and individual scholars. More than 400 clients based in 25 countries choose Interfolio’s solutions for hiring and recruitment, academic appointments and timelines, activity data reporting, faculty reviews and promotions, and research impact analysis. Interfolio provides scholar-first products for the full academic lifecycle—from job seeking to professional accomplishments, committee service, funding award compliance, career growth and advancement, administrative leadership, and beyond. For more information about Interfolio, please visit www.interfolio.com(opens in new tab/window).

About RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs more than 33,000 people over 40% of whom are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York stock exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately £43.2bn/ €50.7bn/ $54.4bn.

About Elsevier

As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, academic leaders, funders, R&D-intensive corporations, doctors, and nurses.  

Elsevier employs 9,000 people worldwide, including over 2,500 technologists. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect,  Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, medical education, and nursing education. Researchers and healthcare professionals rely on over 2,800 journals, including The Lancet(opens in new tab/window) and Cell(opens in new tab/window); 46,000+ eBook titles; and iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation(opens in new tab/window) and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. 

Elsevier is part of RELX(opens in new tab/window), a global provider of information-based analytics and decision tools for professional and business customers.